Piedmont Cancer Institute — Newnan, Georgia

Piedmont Cancer Institute is a clinical research site located in Newnan, Georgia, United States 30265.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Piedmont Cancer Institute has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: mCRPC, Metastatic Pancreatic Cancer.

Sponsors: Pfizer, Piedmont Cancer Institute.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Newnan

Browse all research sites in Georgia · View every site in Newnan

• Piedmont Newnan Hospital
• MedaPhase
• CTCA at Southeastern Regional Medical Center
• Southeastern Regional Medical Center
• Better Health Clinical Research
• Research Site
• Vista Clinical Research
• Cancer Treatment Centers of America
• City of Hope Atlanta Cancer Center
• City of Hope Atlanta
• Digestive Research Associates
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Piedmont Cancer Institute?

Piedmont Cancer Institute has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Piedmont Cancer Institute conducted?

Piedmont Cancer Institute has 2 clinical trials on record, with 1 currently active. Their work covers mCRPC, Metastatic Pancreatic Cancer.

Is Piedmont Cancer Institute accredited by Crixeo Clinical Trials?

Piedmont Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Piedmont Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.